Industry: Service & Software
Published Date: 2026-04-30
Pages: 126 Pages
Report ld: 6699252
Request Sample
Customized Report
Cell Immortalization Market Size(US$)

CAGR 2026-2032
5.9%
Market Size,2032
USD 5,461
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Cell Immortalization market was valued at US$ 3642 million in 2025 and is anticipated to reach US$ 5461 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Cell immortalization refers to the biological process of enabling primary cells to exceed their inherent proliferative limits and gain unlimited division capacity through physical, chemical, or biological means. Normal somatic cells have a limited number of passages in vitro, while immortalization extends cell life and establishes stable cell lines by activating telomerase (e.g., hTERT gene transfection), inactivating tumor suppressor proteins (p53/Rb, such as HPV E6/E7 or SV40 large T antigen), or viral transformation (EBV). Immortalized cells can maintain their original differentiation characteristics and genotype for a long period and are widely used in fields such as tumor research, drug screening, vaccine production, and gene therapy. Representative immortalization technologies include telomerase overexpression, proto-oncogene induction, and spontaneous immortalization. This technology is one of the core tools for modern biomedical basic research and product development.
The global cell immortalization market and research are characterized by a pattern of technological leadership from Europe and the United States, and accelerated application and translation in the Asia-Pacific region. North America, as a leading birthplace, continues to innovate in CRISPR, iPSC reprogramming, and telomerase regulation technologies. Companies such as ATCC and Thermo Fisher provide standard immortalization kits and cell banks, widely used in target discovery and gene therapy. Europe has a deep foundation in tumor biology and mechanism research. ECACC and DSMZ have extremely high requirements for the traceability and ethical standards of immortalized cell lines, promoting the international circulation of high-quality cell resources. The Asia-Pacific region (China, Japan, and South Korea) is experiencing rapid growth in the development of novel immortalization vectors (lentiviruses, transposons) and the construction of industrialized cell lines, especially driven by CRO/CDMO and biosimilars, with strong demand for industrial-grade suspension-acclimated immortalized cell lines (such as HEK293 and CHO). Future trends include: conditional immortalization systems based on CRISPRa/i, non-transgenic transient immortalization technologies, and alternative methods that reduce the use of primary animals in accordance with the 3R principle. Obstacles: Immortification may alter the original cell phenotype; long-term passage leads to karyotype instability, and regulatory concerns about tumorigenicity increase the difficulty of review. Updates: FDA guidelines encourage the use of fully characterized immortalized cell lines to replace animal experiments; China's CDE has released guidelines for stable cell lines used in gene therapy products, and the industry is actively promoting animal-free immortalized reagents.
This report delivers a comprehensive overview of the global Cell Immortalization market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Immortalization. The Cell Immortalization market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cell Immortalization market comprehensively. Regional market sizes by Type, by Application, by Cell Types, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell Immortalization manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Cell Types, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cell Immortalization companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Immortalization Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Stem Cell Therapy
1.2.3 Cell Transplantation
1.2.4 Drug Transport
1.2.5 Others
1.3 Market by Cell Types
1.3.1 Global Cell Immortalization Market Size Growth Rate by Cell Types: 2021 vs 2025 vs 2032
1.3.2 Human Cells
1.3.3 Mouse Cells
1.3.4 Non-mammal Cells
1.3.5 Others
1.4 Market by Doubling Time
1.4.1 Global Cell Immortalization Market Size Growth Rate by Doubling Time: 2021 vs 2025 vs 2032
1.4.2 >30h
1.4.3 24-30h
1.4.4 18-24h
1.4.5 <18h
1.5 Market by Application
1.5.1 Global Cell Immortalization Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Pharmaceutical and Biopharmaceutical Company
1.5.3 Research Laboratory
1.5.4 Hospital
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Cell Immortalization Market Perspective (2021–2032)
2.2 Global Cell Immortalization Growth Trends by Region
2.2.1 Global Cell Immortalization Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell Immortalization Historic Market Size by Region (2021–2026)
2.2.3 Cell Immortalization Forecasted Market Size by Region (2027–2032)
2.3 Cell Immortalization Market Dynamics
2.3.1 Cell Immortalization Industry Trends
2.3.2 Cell Immortalization Market Drivers
2.3.3 Cell Immortalization Market Challenges
2.3.4 Cell Immortalization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Immortalization Players by Revenue
3.1.1 Global Top Cell Immortalization Players by Revenue (2021–2026)
3.1.2 Global Cell Immortalization Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell Immortalization Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell Immortalization Revenue
3.4 Global Cell Immortalization Market Concentration Ratio
3.4.1 Global Cell Immortalization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Immortalization Revenue in 2025
3.5 Global Key Players of Cell Immortalization Head Offices and Areas Served
3.6 Global Key Players of Cell Immortalization, Products and Applications
3.7 Global Key Players of Cell Immortalization, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell Immortalization Breakdown Data by Type
4.1 Global Cell Immortalization Historic Market Size by Type (2021–2026)
4.2 Global Cell Immortalization Forecasted Market Size by Type (2027–2032)
5 Cell Immortalization Breakdown Data by Application
5.1 Global Cell Immortalization Historic Market Size by Application (2021–2026)
5.2 Global Cell Immortalization Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell Immortalization Market Size (2021–2032)
6.2 North America Cell Immortalization Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell Immortalization Market Size by Country (2021–2026)
6.4 North America Cell Immortalization Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Immortalization Market Size (2021–2032)
7.2 Europe Cell Immortalization Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell Immortalization Market Size by Country (2021–2026)
7.4 Europe Cell Immortalization Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell Immortalization Market Size (2021–2032)
8.2 Asia-Pacific Cell Immortalization Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell Immortalization Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell Immortalization Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell Immortalization Market Size (2021–2032)
9.2 Latin America Cell Immortalization Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell Immortalization Market Size by Country (2021–2026)
9.4 Latin America Cell Immortalization Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Immortalization Market Size (2021–2032)
10.2 Middle East & Africa Cell Immortalization Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell Immortalization Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell Immortalization Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Cell Immortalization Introduction
11.1.4 Lonza Revenue in Cell Immortalization Business (2021–2026)
11.1.5 Lonza Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Cell Immortalization Introduction
11.2.4 Thermo Fisher Scientific Revenue in Cell Immortalization Business (2021–2026)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 JSR
11.3.1 JSR Company Details
11.3.2 JSR Business Overview
11.3.3 JSR Cell Immortalization Introduction
11.3.4 JSR Revenue in Cell Immortalization Business (2021–2026)
11.3.5 JSR Recent Development
11.4 Sartorius
11.4.1 Sartorius Company Details
11.4.2 Sartorius Business Overview
11.4.3 Sartorius Cell Immortalization Introduction
11.4.4 Sartorius Revenue in Cell Immortalization Business (2021–2026)
11.4.5 Sartorius Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Cell Immortalization Introduction
11.5.4 Merck Revenue in Cell Immortalization Business (2021–2026)
11.5.5 Merck Recent Development
11.6 AcceGen
11.6.1 AcceGen Company Details
11.6.2 AcceGen Business Overview
11.6.3 AcceGen Cell Immortalization Introduction
11.6.4 AcceGen Revenue in Cell Immortalization Business (2021–2026)
11.6.5 AcceGen Recent Development
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Details
11.7.2 Creative Biolabs Business Overview
11.7.3 Creative Biolabs Cell Immortalization Introduction
11.7.4 Creative Biolabs Revenue in Cell Immortalization Business (2021–2026)
11.7.5 Creative Biolabs Recent Development
11.8 InSCREENex GmbH
11.8.1 InSCREENex GmbH Company Details
11.8.2 InSCREENex GmbH Business Overview
11.8.3 InSCREENex GmbH Cell Immortalization Introduction
11.8.4 InSCREENex GmbH Revenue in Cell Immortalization Business (2021–2026)
11.8.5 InSCREENex GmbH Recent Development
11.9 BioIVT
11.9.1 BioIVT Company Details
11.9.2 BioIVT Business Overview
11.9.3 BioIVT Cell Immortalization Introduction
11.9.4 BioIVT Revenue in Cell Immortalization Business (2021–2026)
11.9.5 BioIVT Recent Development
11.10 Krishgen Biosystems
11.10.1 Krishgen Biosystems Company Details
11.10.2 Krishgen Biosystems Business Overview
11.10.3 Krishgen Biosystems Cell Immortalization Introduction
11.10.4 Krishgen Biosystems Revenue in Cell Immortalization Business (2021–2026)
11.10.5 Krishgen Biosystems Recent Development
11.11 Applied Biological Materials
11.11.1 Applied Biological Materials Company Details
11.11.2 Applied Biological Materials Business Overview
11.11.3 Applied Biological Materials Cell Immortalization Introduction
11.11.4 Applied Biological Materials Revenue in Cell Immortalization Business (2021–2026)
11.11.5 Applied Biological Materials Recent Development
11.12 REPROCELL Inc
11.12.1 REPROCELL Inc Company Details
11.12.2 REPROCELL Inc Business Overview
11.12.3 REPROCELL Inc Cell Immortalization Introduction
11.12.4 REPROCELL Inc Revenue in Cell Immortalization Business (2021–2026)
11.12.5 REPROCELL Inc Recent Development
11.13 FUJIFILM Wako Pure Chemical Corporation
11.13.1 FUJIFILM Wako Pure Chemical Corporation Company Details
11.13.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
11.13.3 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Introduction
11.13.4 FUJIFILM Wako Pure Chemical Corporation Revenue in Cell Immortalization Business (2021–2026)
11.13.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
11.14 Abace Biotechnology
11.14.1 Abace Biotechnology Company Details
11.14.2 Abace Biotechnology Business Overview
11.14.3 Abace Biotechnology Cell Immortalization Introduction
11.14.4 Abace Biotechnology Revenue in Cell Immortalization Business (2021–2026)
11.14.5 Abace Biotechnology Recent Development
11.15 CELLCOOK
11.15.1 CELLCOOK Company Details
11.15.2 CELLCOOK Business Overview
11.15.3 CELLCOOK Cell Immortalization Introduction
11.15.4 CELLCOOK Revenue in Cell Immortalization Business (2021–2026)
11.15.5 CELLCOOK Recent Development
11.16 Procell
11.16.1 Procell Company Details
11.16.2 Procell Business Overview
11.16.3 Procell Cell Immortalization Introduction
11.16.4 Procell Revenue in Cell Immortalization Business (2021–2026)
11.16.5 Procell Recent Development
11.17 Takara Bio
11.17.1 Takara Bio Company Details
11.17.2 Takara Bio Business Overview
11.17.3 Takara Bio Cell Immortalization Introduction
11.17.4 Takara Bio Revenue in Cell Immortalization Business (2021–2026)
11.17.5 Takara Bio Recent Development
11.18 Corning
11.18.1 Corning Company Details
11.18.2 Corning Business Overview
11.18.3 Corning Cell Immortalization Introduction
11.18.4 Corning Revenue in Cell Immortalization Business (2021–2026)
11.18.5 Corning Recent Development
11.19 Evercyte
11.19.1 Evercyte Company Details
11.19.2 Evercyte Business Overview
11.19.3 Evercyte Cell Immortalization Introduction
11.19.4 Evercyte Revenue in Cell Immortalization Business (2021–2026)
11.19.5 Evercyte Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Cell Immortalization was estimated to be worth US$ 3642 million in 2025 and is projected to reach US$ 5461 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-30
Pages: 130
USD 3950.00
(Single User License)
The global Cell Immortalization market size was US$ 3642 million in 2025 and is forecast to reach a readjusted size of US$ 5461 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-04-30
Pages: 139
USD 4250.00
(Single User License)
The global Cell Immortalization market is projected to grow from US$ 3642 million in 2025 to US$ 5461 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-04-30
Pages: 159
USD 4900.00
(Single User License)
The global Cell Immortalization market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 107
USD 4250.00
(Single User License)
The global Cell Immortalization market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 149
USD 4900.00
(Single User License)
The global market for Cell Immortalization was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 131
USD 3950.00
(Single User License)
The global market for Cell Immortalization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-07
Pages: 93
USD 2900.00
(Single User License)
The global Cell Immortalization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-26
Pages: 90
USD 2900.00
(Single User License)
The global market for Cell Immortalization was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 127
USD 3950.00
(Single User License)
The global market for Cell Immortalization was estimated to be worth US$ 3642 million in 2025 and is projected to reach US$ 5461 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-30
Pages: 130
The global Cell Immortalization market size was US$ 3642 million in 2025 and is forecast to reach a readjusted size of US$ 5461 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-04-30
Pages: 139
The global Cell Immortalization market is projected to grow from US$ 3642 million in 2025 to US$ 5461 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-04-30
Pages: 159
The global Cell Immortalization market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 107
The global Cell Immortalization market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 149
The global market for Cell Immortalization was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 131
The global market for Cell Immortalization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 93
The global Cell Immortalization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-26
Pages: 90
The global market for Cell Immortalization was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 127
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now